Showing results (111-120 of 1,902) with videos related to
Sort By:
Pageof 191
Journal of Youth and Adolescence|July 29, 2009
Adolescents' reports of parental engagement and academic achievement in immigrant familiesScott W Plunkett, Andrew O Behnke, Tovah Sands, et al.Child Development|April 1, 1991
Time sampling: a methodological critiqueJ Mann, T Ten Have, J W Plunkett, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Mitoxantrone-induced DNA damage in leukemia cells is enhanced by treatment with high-dose arabinosylcytosineV Heinemann, D Murray, R Walters, et al.Children (Basel, Switzerland)|April 3, 2021
Neighborhood, Peer, and Parental Influences on Minor and Major Substance Use of Latino and Black AdolescentsMarika Sigal, Bryan J Ross, Andrew O Behnke, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumorsN Touroutoglou, D Gravel, M N Raber, et al.Clinics in Dermatology|June 12, 2012
Comparisons of pathologic and normal skin reactive autoantibodies and the interference phenomenonErnst H Beutner, Raminder K Grover, Richard W Plunkett, et al.Leukemia|September 1, 1987
Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemiaL Danhauser, W Plunkett, J Liliemark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology studyR Grunewald, H Kantarjian, M Du, et al.Leukemia & Lymphoma|January 1, 1993
Chronic lymphocytic leukemia--correlation of response and survivalM J Keating, S O'Brien, L Robertson, et al.Blood Reviews|September 1, 1994
The role of fludarabine in hematological malignanciesS J Wright, L E Robertson, S O'Brien, et al.Pageof 191